Problems of real-world evidence studies: qualitative survey of industry representatives

Medical Technologies. Assessment and Choice · Published 2026-06-26 · DOI 10.17116/medtech20264802123

Free full text

Authors (2)

Yu.V. Khomitskaya, T.A. Goldina

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Khomitskaya, Y., Goldina, T. (2026). Problems of real-world evidence studies: qualitative survey of industry representatives. Medical Technologies. Assessment and Choice. https://doi.org/10.17116/medtech20264802123

Related articles

• View of students and residents studying at the university on programs for young specialist support in health care · Medical Technologies. Assessment and Choice · 2025 · Same journal
• The Webiomed.DHRA decision-making support system for medical examinations in the Russian Federation: a cost-effectiveness analysis · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Models of adaptation to professional activity on the example of health care provider · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Early diagnosis and treatment of type 1 diabetes mellitus. Issues of clinical feasibility, organization, and accessibility of medical care. Resolution on the results of the Expert Council held on December 17, 2024, Moscow · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Compliance with short-team follow-up in BI-RADS 3 patients · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Cost-effectiveness analysis of screening for type 1 diabetes in children in the Russian Federation · Medical Technologies. Assessment and Choice · 2026 · Same journal
• Innovation readiness assessment in healthcare organizations · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Experience of telemedicine technologies for pediatric oncology-hematology in the constituent entities of the Russian Federation · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Sales of antipsychotics and anticonvulsants in the Russian Federation for the period 2019—2024 · Medical Technologies. Assessment and Choice · 2026 · Same journal
• Clinical and economic consequences associated with expanding drug reimbursement for patients with chronic obstructive pulmonary disease · Medical Technologies. Assessment and Choice · 2026 · Same journal